MAOA and Parkinson disease: In order to further ascertain this increase in MAO-A in the six PD subjects, we prepared [18F]FEH, a known fluorine-18 analog of [11C]Harmine MAO-A radiotracer [20], and tested the CN and PD subjects’ brains.